• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Human immunodeficiency virus fitness in vivo: calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptase.人类免疫缺陷病毒在体内的适应性:基于逆转录酶第215位密码子单个齐多夫定耐药性突变的计算。
J Virol. 1996 Aug;70(8):5662-4. doi: 10.1128/JVI.70.8.5662-5664.1996.
2
Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine.携带D67N或K219Q/E突变的1型人类免疫缺陷病毒在体外迅速演变为对齐多夫定耐药,并且在有齐多夫定存在的情况下显示出高复制适应性。
J Virol. 2004 Jul;78(14):7545-52. doi: 10.1128/JVI.78.14.7545-7552.2004.
3
Broad spectrum of in vivo fitness of human immunodeficiency virus type 1 subpopulations differing at reverse transcriptase codons 41 and 215.1型人类免疫缺陷病毒亚群在逆转录酶密码子41和215处存在差异,其体内适应性具有广泛的谱系。
J Virol. 1997 Jun;71(6):4479-84. doi: 10.1128/JVI.71.6.4479-4484.1997.
4
Effect of the Q207D mutation in HIV type 1 reverse transcriptase on zidovudine susceptibility and replicative fitness.1型人类免疫缺陷病毒逆转录酶中Q207D突变对齐多夫定敏感性和复制适应性的影响。
J Acquir Immune Defic Syndr. 2005 Sep 1;40(1):20-3. doi: 10.1097/01.qai.0000172369.82456.36.
5
Establishment of new transmissible and drug-sensitive human immunodeficiency virus type 1 wild types due to transmission of nucleoside analogue-resistant virus.由于核苷类似物耐药病毒的传播而产生新的可传播且对药物敏感的1型人类免疫缺陷病毒野生型。
J Virol. 2001 Jan;75(2):595-602. doi: 10.1128/JVI.75.2.595-602.2001.
6
The reverse transcriptase codon 69 insertion is observed in nucleoside reverse transcriptase inhibitor-experienced HIV-1-infected individuals, including those without prior or concurrent zidovudine therapy.在接受过核苷类逆转录酶抑制剂治疗的HIV-1感染个体中观察到逆转录酶密码子69插入,包括那些未曾接受过齐多夫定治疗或同时未接受齐多夫定治疗的个体。
J Hum Virol. 1999 Sep-Oct;2(5):290-5.
7
HIV-1 reverse transcriptase codon 215 mutation in plasma RNA: immunologic and virologic responses to zidovudine. The AIDS Clinical Trials Group Study 175 Virology Team.血浆RNA中HIV-1逆转录酶密码子215突变:对齐多夫定的免疫和病毒学反应。艾滋病临床试验组研究175病毒学团队。
J Acquir Immune Defic Syndr Hum Retrovirol. 1998 Mar 1;17(3):203-8. doi: 10.1097/00042560-199803010-00003.
8
Prevalence of primary resistance to zidovudine and lamivudine in drug-naive human immunodeficiency virus type-1 infected patients: high proportion of reverse transcriptase codon 215 mutant in circulating lymphocytes and free virus.初治的人类免疫缺陷病毒1型感染患者中对齐多夫定和拉米夫定原发性耐药的患病率:循环淋巴细胞和游离病毒中逆转录酶密码子215突变比例高。
J Med Virol. 2000 Jul;61(3):352-9.
9
Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants.在感染齐多夫定耐药变异株的血清转化者中,人类免疫缺陷病毒1型逆转录酶基因密码子215处出现不寻常氨基酸的转换。
J Virol. 1998 May;72(5):3520-3. doi: 10.1128/JVI.72.5.3520-3523.1998.
10
A fossil record of zidovudine resistance in transmitted isolates of HIV-1.HIV-1传播株中齐多夫定耐药性的化石记录。
Proc Natl Acad Sci U S A. 2001 Nov 20;98(24):13485-7. doi: 10.1073/pnas.251559398.

引用本文的文献

1
Consensus Sequences for and Introduced into HIV-1 Clade B Laboratory Strains Differentially Influence the Impact of Point Mutations Associated with Immune Escape and with Drug Resistance on Viral Replicative Capacity.引入HIV-1 B亚型实验室毒株的[具体内容]和[具体内容]的共有序列对与免疫逃逸及耐药相关的点突变对病毒复制能力的影响产生不同作用。
Viruses. 2025 Jun 12;17(6):842. doi: 10.3390/v17060842.
2
Inherently interpretable position-aware convolutional motif kernel networks for biological sequencing data.用于生物测序数据的固有可解释位置感知卷积基元核网络。
Sci Rep. 2023 Oct 11;13(1):17216. doi: 10.1038/s41598-023-44175-7.
3
Emergence and expansion of SARS-CoV-2 B.1.526 after identification in New York.在纽约发现后,SARS-CoV-2 B.1.526 的出现和传播。
Nature. 2021 Sep;597(7878):703-708. doi: 10.1038/s41586-021-03908-2. Epub 2021 Aug 24.
4
Emergence and Expansion of the SARS-CoV-2 Variant B.1.526 Identified in New York.在纽约发现的严重急性呼吸综合征冠状病毒2(SARS-CoV-2)变异株B.1.526的出现与传播
medRxiv. 2021 Aug 4:2021.02.23.21252259. doi: 10.1101/2021.02.23.21252259.
5
The Effects of Population Size Histories on Estimates of Selection Coefficients from Time-Series Genetic Data.种群大小历史对基于时间序列遗传数据的选择系数估计的影响
Mol Biol Evol. 2016 Nov;33(11):3002-3027. doi: 10.1093/molbev/msw173. Epub 2016 Aug 22.
6
Highly-sensitive allele-specific PCR testing identifies a greater prevalence of transmitted HIV drug resistance in Japan.高灵敏度等位基因特异性PCR检测显示日本HIV传播耐药性的流行率更高。
PLoS One. 2013 Dec 16;8(12):e83150. doi: 10.1371/journal.pone.0083150. eCollection 2013.
7
Harnessing DNA synthesis to develop rapid responses to emerging and pandemic pathogens.利用DNA合成技术来开发对新出现的和大流行性病原体的快速应对措施。
J Pathog. 2011;2011:765763. doi: 10.4061/2011/765763. Epub 2011 Mar 16.
8
Design requirements for interfering particles to maintain coadaptive stability with HIV-1.干扰粒子与 HIV-1 保持共适应稳定性的设计要求。
J Virol. 2013 Feb;87(4):2081-93. doi: 10.1128/JVI.02741-12. Epub 2012 Dec 5.
9
A Guide to HIV-1 Reverse Transcriptase and Protease Sequencing for Drug Resistance Studies.用于耐药性研究的HIV-1逆转录酶和蛋白酶测序指南。
HIV Seq Compend. 2001;2001:1-51.
10
What do mathematical models tell us about the emergence and spread of drug-resistant HIV?数学模型能告诉我们耐药性 HIV 的出现和传播情况吗?
Curr Opin HIV AIDS. 2011 Mar;6(2):131-40. doi: 10.1097/COH.0b013e328343ad03.

本文引用的文献

1
First case of new infection with zidovudine-resistant HIV-1 among prospectively studied intravenous drug users and homosexual men in Amsterdam, The Netherlands.荷兰阿姆斯特丹前瞻性研究的静脉吸毒者和男同性恋者中出现首例对齐多夫定耐药的HIV-1新感染病例。
AIDS. 1996 Feb;10(2):231-2. doi: 10.1097/00002030-199602000-00017.
2
HIV-1 dynamics in vivo: virion clearance rate, infected cell life-span, and viral generation time.体内HIV-1动态变化:病毒体清除率、受感染细胞寿命及病毒生成时间。
Science. 1996 Mar 15;271(5255):1582-6. doi: 10.1126/science.271.5255.1582.
3
Sensitive procedure for the amplification of HIV-1 RNA using a combined reverse-transcription and amplification reaction.一种使用逆转录和扩增反应相结合的方法对HIV-1 RNA进行扩增的灵敏程序。
Biotechniques. 1995 Aug;19(2):178-80, 182.
4
Pol gene quasispecies of human immunodeficiency virus: mutations associated with drug resistance in virus from patients undergoing no drug therapy.人类免疫缺陷病毒的Pol基因准种:来自未接受药物治疗患者的病毒中与耐药性相关的突变
J Virol. 1995 Jan;69(1):23-31. doi: 10.1128/JVI.69.1.23-31.1995.
5
Syncytium-inducing (SI) phenotype suppression at seroconversion after intramuscular inoculation of a non-syncytium-inducing/SI phenotypically mixed human immunodeficiency virus population.肌肉注射非合胞体诱导/合胞体诱导表型混合的人类免疫缺陷病毒群体后,血清转化时合胞体诱导(SI)表型的抑制。
J Virol. 1995 Mar;69(3):1810-8. doi: 10.1128/JVI.69.3.1810-1818.1995.
6
HIV population dynamics in vivo: implications for genetic variation, pathogenesis, and therapy.体内HIV群体动力学:对基因变异、发病机制及治疗的影响
Science. 1995 Jan 27;267(5197):483-9. doi: 10.1126/science.7824947.
7
Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection.HIV-1感染中血浆病毒粒子和CD4淋巴细胞的快速周转。
Nature. 1995 Jan 12;373(6510):123-6. doi: 10.1038/373123a0.
8
Exponential increases of RNA virus fitness during large population transmissions.RNA病毒在大规模群体传播期间适应性的指数增长。
Proc Natl Acad Sci U S A. 1995 Jun 20;92(13):5841-4. doi: 10.1073/pnas.92.13.5841.
9
Viral dynamics in human immunodeficiency virus type 1 infection.1型人类免疫缺陷病毒感染中的病毒动力学
Nature. 1995 Jan 12;373(6510):117-22. doi: 10.1038/373117a0.
10
Interactions between drug resistance mutations in human immunodeficiency virus type 1 reverse transcriptase.1型人类免疫缺陷病毒逆转录酶中耐药性突变之间的相互作用
J Gen Virol. 1994 May;75 ( Pt 5):951-7. doi: 10.1099/0022-1317-75-5-951.

人类免疫缺陷病毒在体内的适应性:基于逆转录酶第215位密码子单个齐多夫定耐药性突变的计算。

Human immunodeficiency virus fitness in vivo: calculations based on a single zidovudine resistance mutation at codon 215 of reverse transcriptase.

作者信息

Goudsmit J, De Ronde A, Ho D D, Perelson A S

机构信息

Department of Human Retrovirology, Academic Medical Center, University of Amsterdam, The Netherlands.

出版信息

J Virol. 1996 Aug;70(8):5662-4. doi: 10.1128/JVI.70.8.5662-5664.1996.

DOI:10.1128/JVI.70.8.5662-5664.1996
PMID:8764084
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC190530/
Abstract

We monitored a subject newly infected with a zidovudine-resistant human immunodeficiency virus type 1 strain and found that in the absence of drug, the viral population with the resistance-conferring tyrosine (TAC) codon 215 of reverse transcriptase was gradually replaced. By using standard formulas to model the effects of selection at a single locus in an asexual haploid population, the relative fitness gain of the viral population with a single mutation at codon 215 creating a serine (TCC) was calculated. We concluded that a viral population with a serine at reverse transcriptase codon 215 conferring zidovudine sensitivity was between 0.4 and 2.3% more fit.

摘要

我们监测了一名新感染对齐多夫定耐药的1型人类免疫缺陷病毒毒株的受试者,发现在无药物情况下,具有逆转录酶第215位赋予耐药性的酪氨酸(TAC)密码子的病毒群体逐渐被取代。通过使用标准公式来模拟在无性单倍体群体中单个位点选择的影响,计算了在第215位密码子发生单一突变产生丝氨酸(TCC)的病毒群体的相对适应性增益。我们得出结论,逆转录酶第215位密码子为丝氨酸且赋予齐多夫定敏感性的病毒群体的适应性高0.4%至2.3%。